Open AccessTherapeutic and Vaccine Strategies Against SARS-CoV-2: past, Present and Future
Author(s) -
Mubasher Rehman,
Isfahan Tauseef,
Bibi Aalia,
Sajid Hussain Shah,
Muhammad Junaid,
Kashif Syed Haleem
Publication year - 2020
Publication title -
future virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.462
H-Index - 34
eISSN - 1746-0808
pISSN - 1746-0794
DOI - 10.2217/fvl-2020-0137
Subject(s) - covid-19 , medicine , intensive care medicine , coronavirus , disease , pandemic , global health , virology , infectious disease (medical specialty) , public health , outbreak , pathology
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019. It was first reported in Wuhan, China and has since become a global health concern. Keeping in view, the magnitude of the problem, scientists around the globe are working to develop effective therapeutic strategies. This review focuses on previous findings regarding SARS-CoV, which may prove helpful in future research on SARS-CoV-2. In addition, it also highlights recent developments in medicine and biotechnology toward developing effective drugs and vaccines against SARS-CoV-2. This review will analyze available data on this topic and will help researchers develop new thoughts using information already available as a step toward developing novel therapeutic strategies against SARS-CoV-2.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom